• Mashup Score: 9
    ctDNA in Cancer Treatment and Clinical Care (Overview) | Events Registration - 8 month(s) ago

    Overview The NCI’s Cancer Diagnosis Program in the Division of Cancer Treatment and Diagnosis is hosting a workshop on circulating tumor DNA (ctDNA) in cancer treatment and clinical care. Previously, a workshop was held in 2016focused on promoting the translation of ctDNA assays into clinical research. In the intervening years, much progress has been made in the fast-evolving field of ctDNA, and clinical utility has been demonstrated.

    Source: events.cancer.gov
    Categories: Latest Headlines, Oncologists1
    Tweet Tweets with this article
    • Profile photo of aparna1024
      aparna1024

      💪🏽 start to day when you’re 1st in line at @dunkindonuts when it opens at 4:30 am @BostonLogan & line is already 50 ish people long. Thrilled to be @NCICancerCtrl for the 1st time for all things ctDNA. Amazing line up & excited for 2 days of learning https://t.co/nFKyNsEcqr

  • Mashup Score: 8
    Immunosuppressive niche engineering at the onset of human colorectal cancer - Nature Communications - 12 month(s) ago

    Integration of mathematical modeling, ecological analyses of patient biopsies, and neoantigen heterogeneity suggests recruitment of immunosuppressive cells is key to initializing transformation from adenoma to carcinoma in human colorectal cancer.

    Source: Nature
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of aparna1024
      aparna1024

      A2-1 📌🔥tumors have lots of immune cells 📌🧊tumors have very little immune cell infiltration Here’s 👇a great model illustrating the origins of CRC. As adenomas progress to carcinomas it becomes less immunogenic & more immunosuppressive. https://t.co/CIHJuGZtk8 #CRCTrialsChat https://t.co/DyLfYVFNGC

  • Mashup Score: 2
    The emerging promise of liquid biopsies in solid tumors - 1 year(s) ago

    Liquid biopsies of circulating tumor DNA offer a non-invasive tool with many potential applications in oncology, including early cancer detection, profiling, disease prognosis, prediction of therapy response and monitoring disease status. A growing body of literature and clinical trials support an increasingly valuable role for liquid biopsies in the care of patients with solid malignancies.

    Source: www.nature.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of aparna1024
      aparna1024

      Beyond GI cancers a bit but VERY brief report on all that's to come in liquid biopsy space. excited for an upcoming MRD project in 2023 with these co-authors including my senior fellow, @VanMorrisMD and some of our Japanese collaborators https://t.co/Ivj1fq3H33

  • Mashup Score: 0
    Overcoming Our Red Dots and Confronting Racism From Patients - 2 year(s) ago

    This essay describes the author’s experiences facing racism from patients and recommendations for ways to create more inclusive environments for physicians who experience racism.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of aparna1024
      aparna1024

      Ah the dot comment. piece that resonated “triumphs of Indian American people in US do not discount or rationalize the racism, discrimination and xenophobia…..nor do they provide cloak of immunity.Paradoxically constrain society from acknowledging” https://t.co/5hcLppUkXT

Load More